By Michael Whiteley, Eastern Bureau ChiefA bill that would cap the price of repackaged drugs cleared a Senate committee on Thursday, but a Senate leader who voted for the cap said he may seek changes to ensure that doctors make some profit from the transactions.The Senate Banking and Insurance Committee voted 7-4 to approve Senate Bill 668 by Sen. Alan Hays, R-Umatilla, and sent the measure along to the Senate Health Regulation Committee for further review. But interviews with lawmakers involved in the debate show that disagreements over just how much the price cap will save, whether carriers ...
Comments